Last update 01 Nov 2024

SRD5A3 x GSPT1

Basic Info

Related Targets
SRD5A3GSPT1

Related

1
Drugs associated with SRD5A3 x GSPT1
DG01
Target
GSPT1 x SRD5A3
Mechanism
GSPT1 degraders [+1]
Active Org.
Suzhou Degen Biomedical Co., Ltd.
Originator Org.
Suzhou Degen Biomedical Co., Ltd.
Active Indication
Castration-Resistant Prostatic Cancer [+2]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with SRD5A3 x GSPT1
CTR20243467 / Not yet recruitingPhase 1
评价 DG01 在前列腺癌患者中的安全性、耐受性、药物代谢动力学特征和初步有效性的Ⅰ 期临床研究
[Translation] Phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of DG01 in patients with prostate cancer
100 Clinical Results associated with SRD5A3 x GSPT1
Login to view more data
100 Translational Medicine associated with SRD5A3 x GSPT1
Login to view more data
0 Patents (Medical) associated with SRD5A3 x GSPT1
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free